{"id":61094,"date":"2024-07-08T18:00:00","date_gmt":"2024-07-08T16:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/"},"modified":"2024-07-23T09:59:43","modified_gmt":"2024-07-23T07:59:43","slug":"half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/","title":{"rendered":"Half-year statement of IPSEN liquidity agreement &#8211; 2024 06 30"},"content":{"rendered":"<p><b>Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF<\/b><\/p>\n<p align=\"justify\"><b>PARIS, FRANCE, July 8, 2024 <\/b>&#8211; Under the liquidity agreement entrusted by IPSEN SA to NATIXIS ODDO BHF, as of June 30, 2024, the following resources were included to the dedicated liquidity account:<\/p>\n<ul>\n<li>34,591 shares<\/li>\n<li>\u20ac1,418,034.45 <\/li>\n<\/ul>\n<p align=\"justify\">It is reminded that as of the date of the signature of the agreement, the following assets were allocated to the liquidity account:<\/p>\n<ul>\n<li>12,751 shares<\/li>\n<li>\u20ac3,137,934.80<\/li>\n<\/ul>\n<p align=\"justify\">Between January 1<sup>st<\/sup>, 2024 and June 30, 2024 have been executed:<\/p>\n<ul>\n<li>3,232 purchase transactions<\/li>\n<li>2,431 sell transactions<\/li>\n<\/ul>\n<p align=\"justify\">Under the same period, the volumes traded represented:<\/p>\n<ul>\n<li>384,417 shares and \u20ac42,260,402.70 to the purchase<\/li>\n<li>371,870 shares and \u20ac40,869,625.30 to the sell<\/li>\n<\/ul>\n<p id=\"gnw_attachments_section-header\">\n    <strong>Attachment<\/strong>\n<\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n        <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=Dsc9t9Y_LFRGVyO7d7JRkQOIdZ8T5QO5WJPp2id0_1UwRdToE0jGQlW8tJlLEiNLkLu-EYGo6OEXQc1Y2lZT8mPrtucWcBjNAeClVw8FwVJPWkdAZZO84wM8gRy34ugOXhmsBUXvNBc-O0H42_yQBVXzjcCiXTY_PnXS2_JNq1SNJzTFOgO9IVbcP1y1hnpHHt0WRrSPVVl0_klYWGttMQ==\" title=\"IPSEN - PR Half year statement S1 2024 - EN\" rel=\"nofollow noopener\">IPSEN &#8211; PR Half year statement S1 2024 &#8211; EN<\/a>\n      <\/li>\n<\/ul>\n<p><img src='https:\/\/ml-eu.globenewswire.com\/media\/NDg3MzRkZjctMGQ5Zi00ZDA4LTgzOTUtYmZmYmRiZWEwMjdmLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png' \/><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[149],"tags":[],"class_list":["post-61094","press_release","type-press_release","status-publish","hentry","category-pressrelease","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Half-year statement of IPSEN liquidity agreement - 2024 06 30<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Half-year statement of IPSEN liquidity agreement - 2024 06 30\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-23T07:59:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/NDg3MzRkZjctMGQ5Zi00ZDA4LTgzOTUtYmZmYmRiZWEwMjdmLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/\"},\"author\":{\"name\":\"IPSEN\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0\"},\"headline\":\"Half-year statement of IPSEN liquidity agreement &#8211; 2024 06 30\",\"datePublished\":\"2024-07-08T16:00:00+00:00\",\"dateModified\":\"2024-07-23T07:59:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/\"},\"wordCount\":111,\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/NDg3MzRkZjctMGQ5Zi00ZDA4LTgzOTUtYmZmYmRiZWEwMjdmLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png\",\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/\",\"url\":\"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/\",\"name\":\"Half-year statement of IPSEN liquidity agreement - 2024 06 30\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/NDg3MzRkZjctMGQ5Zi00ZDA4LTgzOTUtYmZmYmRiZWEwMjdmLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png\",\"datePublished\":\"2024-07-08T16:00:00+00:00\",\"dateModified\":\"2024-07-23T07:59:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/#primaryimage\",\"url\":\"https:\/\/ml-eu.globenewswire.com\/media\/NDg3MzRkZjctMGQ5Zi00ZDA4LTgzOTUtYmZmYmRiZWEwMjdmLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png\",\"contentUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/NDg3MzRkZjctMGQ5Zi00ZDA4LTgzOTUtYmZmYmRiZWEwMjdmLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Half-year statement of IPSEN liquidity agreement &#8211; 2024 06 30\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/#website\",\"url\":\"https:\/\/www.ipsen.com\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0\",\"name\":\"IPSEN\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g\",\"caption\":\"IPSEN\"},\"sameAs\":[\"https:\/\/www.ipsen.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Half-year statement of IPSEN liquidity agreement - 2024 06 30","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/","og_locale":"en_US","og_type":"article","og_title":"Half-year statement of IPSEN liquidity agreement - 2024 06 30","og_url":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/","og_site_name":"Global","article_modified_time":"2024-07-23T07:59:43+00:00","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/NDg3MzRkZjctMGQ5Zi00ZDA4LTgzOTUtYmZmYmRiZWEwMjdmLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png"}],"twitter_card":"summary_large_image","twitter_site":"@ipsengroup","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/"},"author":{"name":"IPSEN","@id":"https:\/\/www.ipsen.com\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0"},"headline":"Half-year statement of IPSEN liquidity agreement &#8211; 2024 06 30","datePublished":"2024-07-08T16:00:00+00:00","dateModified":"2024-07-23T07:59:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/"},"wordCount":111,"publisher":{"@id":"https:\/\/www.ipsen.com\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/NDg3MzRkZjctMGQ5Zi00ZDA4LTgzOTUtYmZmYmRiZWEwMjdmLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png","articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/","url":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/","name":"Half-year statement of IPSEN liquidity agreement - 2024 06 30","isPartOf":{"@id":"https:\/\/www.ipsen.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/NDg3MzRkZjctMGQ5Zi00ZDA4LTgzOTUtYmZmYmRiZWEwMjdmLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png","datePublished":"2024-07-08T16:00:00+00:00","dateModified":"2024-07-23T07:59:43+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/#primaryimage","url":"https:\/\/ml-eu.globenewswire.com\/media\/NDg3MzRkZjctMGQ5Zi00ZDA4LTgzOTUtYmZmYmRiZWEwMjdmLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png","contentUrl":"https:\/\/ml-eu.globenewswire.com\/media\/NDg3MzRkZjctMGQ5Zi00ZDA4LTgzOTUtYmZmYmRiZWEwMjdmLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/press-releases\/half-year-statement-of-ipsen-liquidity-agreement-2024-06-30-2909852\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/"},{"@type":"ListItem","position":2,"name":"Half-year statement of IPSEN liquidity agreement &#8211; 2024 06 30"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/#website","url":"https:\/\/www.ipsen.com\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0","name":"IPSEN","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g","caption":"IPSEN"},"sameAs":["https:\/\/www.ipsen.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/press_release\/61094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":1,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/press_release\/61094\/revisions"}],"predecessor-version":[{"id":62336,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/press_release\/61094\/revisions\/62336"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/media?parent=61094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/categories?post=61094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/tags?post=61094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}